Woods, Laura M.
Ali, Fahad R.
Gomez, Roshna
Chernukhin, Igor
Marcos, Daniel
Parkinson, Lydia M.
Tayoun, Ahmad N. Abou
Carroll, Jason S.
Philpott, Anna
Funding for this research was provided by:
Cancer Research UK (A25636, A20411 and A31344, A25636, A20411 and A31344, A25636, A20411 and A31344, A25636, A20411 and A31344, A25636, A20411 and A31344, A25636, A20411 and A31344)
Wellcome Trust (212253/Z/18/Z, 203151/Z/16/Z, 212253/Z/18/Z, 203151/Z/16/Z, 212253/Z/18/Z, 203151/Z/16/Z, 212253/Z/18/Z, 203151/Z/16/Z, 212253/Z/18/Z, 203151/Z/16/Z)
Medical Research Council (MC_PC_17230, MC_PC_17230, MC_PC_17230, MC_PC_17230, MC_PC_17230)
MBRU ALMAHMEED Collaborative Research Award ALM1909 (ALM, ALM)
MBRU College of Medicine Internal grant award (MBRU-CM-RG2019–14, MBRU-CM-RG2019–14, MBRU-CM-RG2019–14)
Neuroblastoma UK
Article History
Received: 1 October 2021
Accepted: 23 March 2022
First Online: 3 April 2022
Declarations
:
: This study uses a long-established cell line that is freely available and there are no issue of consent or ethics approvals required that we are aware of.
: Not applicable.
: The authors declare that they have no competing interests.